You are here: Industry Insights > Breast Cancer

News List

Antioxidant, Supplement Use May Worsen Breast Cancer Outcomes drugs
December 27, 2019
Use of antioxidants and other dietary supplements before and during chemotherapy is associated with worse survival outcomes for patients with breast cancer ...
Regular Exercise Cuts Odds for 7 Major Cancers drugs
December 27, 2019
Exercise may reduce the odds you'll develop any of seven types of cancer -- and a new study suggests the more you exercise, the lower your risk.
AZ, Daiichi grab blockbuster nod for breast cancer med Enhertu fiercepharma
December 27, 2019
For metastatic breast cancer patients who try and fail on multiple treatments, finding options to manage disease is a difficult proposition.
Results Mixed for Twice-Daily APBI in Early Breast Cancer drugs
December 26, 2019
Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recurrence (IBTR) ...
Breast Cancer Rates Opposite for Estrogen, Estrogen + Progestin drugs
December 26, 2019
For postmenopausal women, conjugated equine estrogen (CEE) alone is associated with a long-term decrease in breast cancer incidence, while CEE plus medroxyprogesterone acetate (MPA) ...
Permanent Hair Dye Use Linked to Increased Breast Cancer Risk drugs
December 26, 2019
Permanent hair dye use is associated with an increased risk for breast cancer, especially among black women, according to a study published online in the International Journal of Cancer.
Taking certain vitamins during breast cancer chemo tied to recurrence, death firstwordpharma
December 25, 2019
Investigators analyzed data from the Diet, Exercise, Lifestyle and Cancer Prognosis study, which was conducted as part of a trial designed to determine the best dose and schedule of chemotherapy drugs.
Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy drugs
December 25, 2019
Obesity is associated with an increased risk for cardiotoxicity among patients receiving treatment for breast cancer, according to a study published online in PLOS Medicine.
RT for DCIS Ups Mortality Risk in Invasive Second Breast Cancer drugs
December 23, 2019
For women with primary ductal carcinoma in situ (DCIS), use of radiotherapy (RT) is associated with increased rates of breast cancer-specific mortality for those women ...
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies worldpharmanews
December 23, 2019
The U.S. Food and Drug Administration granted accelerated approval to Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adults with unresectable ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page